A Phase II Trial of Irinotecan (CPT-11) and Cyclosporine in Patients With 5-FU Refractory Advanced Colorectal Cancer
Latest Information Update: 13 Feb 2013
At a glance
- Drugs Ciclosporin (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 05 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2005 New trial record.